2021
DOI: 10.1007/s12035-021-02392-z
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic Targeting of Human Olfactory Mucosa Stem Cells Following Intranasal Administration: a Novel Approach to Parkinson’s Disease Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 46 publications
0
17
0
Order By: Relevance
“…Next, the tissue suspension was centrifuged (1800 rpm, 5 min), and the supernatant was removed. After several times repeated this step, the cell pellet was cultured in 25 cm 2 flasks consisting of 10% FBS in DMEM/F12 medium, incubated at 37°C with 5% CO 2 , and the medium was replaced twice a week 38 , 39 . The cells were passaged to reach P3.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Next, the tissue suspension was centrifuged (1800 rpm, 5 min), and the supernatant was removed. After several times repeated this step, the cell pellet was cultured in 25 cm 2 flasks consisting of 10% FBS in DMEM/F12 medium, incubated at 37°C with 5% CO 2 , and the medium was replaced twice a week 38 , 39 . The cells were passaged to reach P3.…”
Section: Methodsmentioning
confidence: 99%
“…medium, incubated at 37 C with 5% CO 2 , and the medium was replaced twice a week. 38,39 The cells were passaged to reach P3. The expression of surface markers of AD-MSCs was tested with the flow cytometry technique to confirm that the harvested cells were stem cells.…”
Section: Preparation Of the 3d-printed Composite Scaffoldmentioning
confidence: 99%
“…Similarly, in experimental autoimmune encephalomyelitis (EAE) models, IN delivery showed a superior in lesion site retention compared with intraperitoneal or intravenous injection and CXCR4 overexpression further enhanced retention of MSCs 78 , 146 . In 6-OHDA-induced PD model, stem cells or EVs were found to gradually accumulate to the striatum and substantia nigra 147 , stem cells or EVs could still be observed months after administration 138 . Meanwhile, the stem cells or EVs in other brain regions, like the olfactory bulb or brainstem, were constantly decreased after administration 136 .…”
Section: Benefits Of Combining Stem Cells or Evs-based Therapy With I...mentioning
confidence: 98%
“… 123 PD model rats Single administration Behavioral performances were improved one week after administration and the improvement remained to 4 weeks. 147 Ischemic stroke and refusion model mice 1 h after modeling, twice a day for 7 days Inflammation was inhibited and histological structure was restored at end of treatment. Behavioral performances were continuously improved during 7-days-treatment.…”
Section: Benefits Of Combining Stem Cells or Evs-based Therapy With I...mentioning
confidence: 99%
“…7,35 Olfactory ectomesenchymal stem cells (OE-MSCs) are a new population of neural crest-derived stem cells obtained from lamina propria of the nasal mucosa by non-invasive methods. 36,37 EMSCs possess the multilineage differentiation and self-renewal capacity and a higher potential than the other sources of stem cells to proliferate and differentiate to neurogenic cells, including SCs. [38][39][40] Also, these stem cells have an immunoregulatory function 41 and lack apoptotic and tumorigenic activities [42][43][44] ; therefore, they can be considered an autologous favorable source for cell therapy in PNIs.…”
Section: Introductionmentioning
confidence: 99%